Technology area: Semiconductors, Circuits & Optics
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Mega Pharm Limited has 1 pending office action in the Semiconductors, Circuits & Optics technology area. This action is located in a distinct art unit and is assigned to a distinct examiner. With only the pending action, the company's current prosecution profile is highly centralized, focusing all activity on a single matter. This allows for a very specific and targeted prosecution strategy that is not fragmented across different technical groups.
ST CYR, DANIEL is the busiest examiner, currently overseeing the pending office action. The single examiner and art unit define the entire current landscape for the company's pending matters. Practitioners should focus entirely on the preferences of the examiner and the standards of the art unit, as they represent the totality of the company's current pending office actions. This concentration ensures that all efforts are aligned with the specific requirements of the examiner within the art unit, as there is only 1 pending office action to manage. The absence of multiple pending matters allows for a deep focus on this individual case.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ST CYR, DANIEL | 1 | 81.3% | +12.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18994279 | PHARMACY-TRANSACTION APPARATUSES AND RELATED METHODS | ST CYR, DANIEL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18994279 | PHARMACY-TRANSACTION APPARATUSES AND RELATED METHODS | ST CYR, DANIEL | — |
| Art Unit | Apps |
|---|---|
| 2876 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18994279 | PHARMACY-TRANSACTION APPARATUSES AND RELATED METHODS | ST CYR, DANIEL | 2876 | §103 | Final Rejection | — | Pending | Jan 14, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMega Pharm Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Daniel St Cyr has the most, with 1 of Mega Pharm Limited's pending office actions.
Mostly Semiconductors, Circuits & Optics (USPTO Tech Center 2800), based on where its pending office actions are examined.
